NCT06380751 2026-04-14
EvoPAR-BR01
AstraZeneca
Phase 3 Recruiting
AstraZeneca
AstraZeneca
Verastem, Inc.
Novartis
Stemline Therapeutics, Inc.
Eli Lilly and Company
Novartis
Olema Pharmaceuticals, Inc.
Eli Lilly and Company
Shandong Suncadia Medicine Co., Ltd.
AstraZeneca
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.